This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PIO
Should You Invest in the Invesco Global Water ETF (PIO)?
by Zacks Equity Research
Sector ETF report for PIO
Danaher (DHR) Q1 Earnings Beat, Revenues Decline 7% Y/Y
by Zacks Equity Research
Danaher's (DHR) Q1 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
Compared to Estimates, Danaher (DHR) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 4.42% and 1.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Walmart, Chevron, Danaher, Intel and Lowe's
by Zacks Equity Research
Walmart, Chevron, Danaher, Intel and Lowe's are included in this Analyst Blog.
Top Analyst Reports for Walmart, Chevron & Danaher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Chevron Corporation (CVX) and Danaher Corporation (DHR).
Honeywell International Inc. (HON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Honeywell International Inc. (HON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $254.76, marking a -0.54% move from the previous day.
Analysts Estimate Danaher (DHR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $255.75, marking a +1.62% move from the previous day.
Can Danaher (DHR) Retain Beat Streak This Earnings Season?
by Zacks Equity Research
Steady demand across end markets within the Life Sciences segment is likely to have aided Danaher's (DHR) Q1 performance. However, cost and supply-chain woes might have hurt the same.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $249.54 in the latest trading session, marking a +1.04% move from the prior day.
Time to Buy Stock in These Conglomerates?
by Shaun Pruitt
With their extensive reach, here are three conglomerates' investors may want to consider as they are top-rated Zack stocks at the moment.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $250.09, marking a -0.77% move from the previous day.
Here's Why You Should Hold on to Danaher (DHR) Stock Now
by Zacks Equity Research
The DBS initiatives, cost management actions and steady demand across major end markets augur well for Danaher's (DHR) growth. Handsome rewards to shareholders add to the stock's appeal.
Danaher (DHR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $247.97 in the latest trading session, marking a -0.08% move from the prior day.
Top Stock Reports for Berkshire Hathaway, Roche & Thermo Fisher Scientific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Roche Holding AG (RHHBY) and Thermo Fisher Scientific Inc. (TMO).
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $248.38, moving +1.46% from the previous trading session.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $242.11, marking a -1.12% move from the previous day.
HTHIY vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HTHIY vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Stock Moves -1.67%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $243.63, marking a -1.67% move from the previous day.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $247.76, moving +1.02% from the previous trading session.
Danaher (DHR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $249.73 in the latest trading session, marking a +1.78% move from the prior day.
The Zacks Analyst Blog Highlights NVIDIA, Visa, Toyota Motor, Costco Wholesale and Danaher
by Zacks Equity Research
NVIDIA, Visa, Toyota Motor, Costco Wholesale and Danaher are included in this Analyst Blog.